Cardiovascular disease in long-term survivors of pediatric Hodgkin's disease

Progress in Pediatric Cardiology

Volumn 8, Issue 3, 1998, Pages 139-144

  Cameron, Elizabeth H ^a   Lipshultz, Steven E ^b   Tarbell, Nancy J ^a   Mauch, Peter M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Departments of Pediatrics and Ophthalmology   (United States)

Author keywords

Anthracycline; Cardiotoxicity; Chemotherapy; Hodgkin's disease; Late effects; Radiation induced heart disease

Indexed keywords

ANTHRACYCLINE; ANTIINFLAMMATORY AGENT; DOXORUBICIN; STEROID;

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHILD; CHYLOTHORAX; CORONARY ARTERY; GONAD DYSFUNCTION; HEART AFTERLOAD; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; LUNG FIBROSIS; MULTIMODALITY CANCER THERAPY; MUSCULOSKELETAL DISEASE; MYXEDEMA; PERICARDIECTOMY; PERICARDITIS; PERICARDIUM; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VALVE STENOSIS; RADIATION DOSE; VALVULAR HEART DISEASE;

EID: 0031894370     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(98)00009-5     Document Type: Article

References (31)

1. Lipshultz SE, Sallan SE Cardiovascular abnormalities in long-term survivors of childhood malignancy. JCO. 11:1993;1199-1203.
2. Bleyer WA The impact of childhood cancer on the United States and the world. CA Cancer J Clin. 40:1990;355-367.
3. Mauch PM, Kalish LA, Marcus KCet al. Long-term survival in Hodgkin's disease: relative impact of mortality, second tumors infection and cardiovascular disease. Cancer J. 1:1995;33-42.
4. Hancock SL, Hoppe RT Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol. 6:1996;225-242.
5. Hancock SL, Tucker MA, Hoppe RT Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. J Am Med Assoc. 270:1993;1949-1955.
6. Mauch P, Hellman S, Belli J Cardiac effects of mediastinal irradiation. N Engl J Med. 309:1983;378.
7. Brosius FC, Waller BF, Roberts WC Radiation heart disease: Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med. 70:1981;519-530.
8. Stewart JR, Fajarado LF, Gillette SM, Constine LS Radiation injury to the heart. Int J Radiat Oncol Biol Phys. 31:1995;1205-1211.
9. Arsenian M Cardiovascular sequelae of therapeutic thoracic radiation. Prog Cardiovasc Dis. 33:1991;299-311.
10. Tarbell NJ, Thompson L, Mauch P Thoracic irradiation in Hodgkin's disease; disease control and long-term complications. Int J Radiat Oncol Biol Phys. 18:1990;275-281.
11. Hancock SL, Donaldson SS, Hoppe RT Cardiac disease following treatment of Hodgkin's disease in children and adolescents. JCO. 11:1993;1208-1215.
12. Cosset JM, Henry-Amar M, Pellae-Cosset Bet al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys. 21:1991;44749.
13. Carmel RJ, Kaplan HS Mantle irradiation in Hodgkin's disease: An analysis of technique, tumor eradication, and complications. Cancer. 37:1976;2813-2825.
14. Cameron J, Osterle SN, Baldwin JCet al. The etiologic spectrum of constrictive pericarditis. Am Heart J Med. 113:1987;354-360.
15. Boivin JF, Hutchinson G, Lubin J, Mauch P Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 69:1992;1241-1247.
16. Mauch P, Tarbell N, Weinstein Het al. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol. 6:1988;1576-1583.
17. Reber D, Birnbaum DE, Tollenaere P Heart disease following mediastinal irradiation: surgical management. Eur J Cardiothor Surg. 9:1995;202-205.
18. Kreuzer ED, Voller H, Behles Cet al. Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease. Br J Haematol. 84:1993;615-622.
19. Weyl Ben Arush M, Solt Y, Bentur Let al. Pulmonary and cardiac sequelae in long-term survivors of childhood lymphomas. Proc ASCO. 16:1997;529a.
20. Steinherz LJ, Steinherz PG, Tan CTCet al. Cardiac toxicity after completing anthracycline therapy. J Am Med Assoc. 166:1991;1672-1677.
21. Lipshultz SE, Colan SD, Gelber RDet al. Late cardiac effects of Doxorubicin therapy for acute Iymphoblastic leukemia in childhood. N Engl J Med. 324:1991;808-815.
22. Valagussa Pk, Santoro A, Bonadonna G Thyroid, pulmonary and cardiac sequelae after treatment for Hodgkin's disease. Ann Oncol. 3(Suppl 4):1992;S111-S115.
23. Morgan GW, Freeman AP, McLean RGet al. Late cardiovascular, thyroid, and pulmonary sequelae for mantle radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 11:1985;1925-1931.
24. Constine LS, Schwartz RG, Savage DEet al. Cardiac function and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys. 39:1997;897-906.
25. Green DM, Gingell RL, Pearce J, Panahon AM, Ghoorah J The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. JCO. 5:1987;239-245.
26. Boivin JF, Hutchinson GB Coronary heart disease mortality after irradiation for Hodgkin's disease. Cancer. 49:1982;2470-2475.
27. Om A, Ellahham S, Vetrovec GW Radiation-induced coronary heart disease. Am Heart J. 6:1992;1598-1602.
28. Piovaccari G, Ferretti R, Prati Fet al. Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up. Int J Cardiol. 49:1995;39-49.
29. Glanzman C, Huguenin P, Lutolf UMet al. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother Oncol. 30:1994;43-54.
30. Gottdiener JS, Katin MJ, Borer JSet al. Late cardiac effects of therapeutic mediastinal irradiation: assessment by echocardiography and radionucleotide angiography. N Engl J Med. 308:1983;569-572.
31. Pohjola-Sintonen S, Totterman KJ, Salmo M, Siltanen P Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer. 60:1994;31-37.